Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells
Microvascular Research · 2024-05 · 153 · 104667
DOI: 10.1016/j.mvr.2024.104667 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microvascular Research, 2024-05. Verfasst von Rohit Patel und 5 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Disorders and Inflammatory Pathologies Laboratory, School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat 382030, Ind…. Hauptthemen laut MEDLINE: Silymarin, Atherosclerosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Science and Engineering Research Board.
Abstract (Originalsprache)
Extracellular signal-regulated kinase (Erk)-5 is a key mediator of endothelial cell homeostasis, and its inhibition causes loss of critical endothelial markers leading to endothelial dysfunction (ED). Circulating oxidized low-density lipoprotein (oxLDL) has been identified as an underlying cause of ED and atherosclerosis in metabolic disorders. Silymarin (Sym), a flavonolignan, possesses various pharmacological activities however its preventive mechanism in ED warrants further investigation. Here, we have examined the effects of Sym in regulating the expression of Erk-5 and ameliorating ED using in vitro and in vivo models. Primary human umbilical vein endothelial cells (pHUVECs) viability was measured by MTT assay; mRNA and protein expression by RT-qPCR and Western blotting; tube-formation assay was performed to examine endothelialness. In in-vivo experiments, normal chow-fed mice (control) or high-fat diet (HFD)-fed mice were administered Sym or Erk-5 inhibitor (BIX02189) and body weight, blood glucose, plasma-LDL, oxLDL levels, and expression of EC markers in the aorta were examined. Sym (5 μg/ml) maintained the viability and tube-formation ability of oxLDL exposed pHUVECs. Sym increased the expression of Erk-5, vWF, and eNOS and decreased ICAM-1 at transcription and translation levels in oxLDL-exposed pHUVECs. In HFD-fed mice, Sym reduced the body weight, blood glucose, LDL-cholesterol, and oxLDL levels, and increased the levels of vWF and eNOS along with Erk-5 and decreased the level of ICAM-1 in the aorta. These data suggest that Sym could be a potent anti-atherosclerotic agent that could elevate Erk-5 level in the ECs and prevent ED caused by oxidized LDL during HFD-induced obesity in mice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Disorders and Inflammatory Pathologies Laboratory, School of Life Sciences, Central University of Gujarat, Gandhinagar, Gujarat 382030, India; Department of Neurology, Brigham and Women's Hospital, Harvard Med…
- School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India.
- School of Life Sciences, Jawaharlal Nehru University, New Delhi 110067, India; Department of Biochemistry, School of Chemical and Life Sciences, Jamia Hamdard University, New Delhi 110062, India.
- Special Centre for Molecular Medicine, Jawaharlal Nehru University, New Delhi 110067, India. Electronic address: ucsyadav@mail.jnu.ac.in.
Förderung
- Science and Engineering Research Board
Zitieren
APA
Patel, R., Kumar, S., Varghese, J. F., Singh, N., Singh, R. P., & Yadav, U. C. S. (2024). Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells. Microvascular Research, 153, 104667. https://doi.org/10.1016/j.mvr.2024.104667
Vancouver
Patel R, Kumar S, Varghese JF, Singh N, Singh RP, Yadav UCS. Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells. Microvascular Research. 2024;153:104667. doi:10.1016/j.mvr.2024.104667
BibTeX
@article{Patel2024,
author = {Patel, Rohit and Kumar, Sanjay and Varghese, Johnna F and Singh, Navneendra and Singh, Rana P and Yadav, Umesh C S},
title = {Silymarin prevents endothelial dysfunction by upregulating Erk-5 in oxidized LDL exposed endothelial cells},
journal = {Microvascular Research},
year = {2024},
volume = {153},
pages = {104667},
doi = {10.1016/j.mvr.2024.104667}
}
EUVIMED